163 related articles for article (PubMed ID: 27964986)
1. Ventricular assist device thrombosis: Mind your P's &Q's-Pumps, patients, and pills.
Massicotte P; Snyder T; Stulak J; Baumann Kreuziger L
J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1503-1506. PubMed ID: 27964986
[No Abstract] [Full Text] [Related]
2. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review.
Baumann Kreuziger LM; Kim B; Wieselthaler GM
J Thromb Haemost; 2015 Jun; 13(6):946-55. PubMed ID: 25845489
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.
Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward CS
Artif Organs; 2013 Mar; 37(3):313-8. PubMed ID: 23373528
[TBL] [Abstract][Full Text] [Related]
4. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy for ventricular assist devices in children: do we really know what to do?
Massicotte MP; Bauman ME; Murray J; Almond CS
J Thromb Haemost; 2015 Jun; 13 Suppl 1():S343-50. PubMed ID: 26149046
[TBL] [Abstract][Full Text] [Related]
6. What is the optimal anticoagulation in patients with a left ventricular assist device?
Rossi M; Serraino GF; Jiritano F; Renzulli A
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
[TBL] [Abstract][Full Text] [Related]
7. Platelet inhibition with ticagrelor for left ventricular assist device thrombosis.
Oliveira GH; Al-Kindi SG; ElAmm C; Qattan MY; Deo S; Medalion B; Benatti RD; Osman MN; Ginwalla M; Park SJ; Simon DI
Circ Heart Fail; 2015 May; 8(3):649-51. PubMed ID: 25991808
[No Abstract] [Full Text] [Related]
8. Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis.
Susen S; Rauch A; Van Belle E; Vincentelli A; Lenting PJ
J Thromb Haemost; 2015 Oct; 13(10):1757-67. PubMed ID: 26302994
[TBL] [Abstract][Full Text] [Related]
9. Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma.
Bhamidipati CM; Ailawadi G; Bergin J; Kern JA
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):e7-8. PubMed ID: 19945118
[No Abstract] [Full Text] [Related]
10. Treatment of Left Ventricular Assist Device Thrombosis: Single-Center Experience.
Beyazpınar DS; Ersoy Ö; Gültekin B; Aliyev A; Avsever M; Akay HT; Özkan M; Sezgin A; Aşlamacı S
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):165-167. PubMed ID: 29528019
[TBL] [Abstract][Full Text] [Related]
11. Assessment of long-term anticoagulation in patients with a continuous-flow left-ventricular assist device: a pilot study.
Jennings D; McDonnell J; Schillig J
J Thorac Cardiovasc Surg; 2011 Jul; 142(1):e1-2. PubMed ID: 21529846
[No Abstract] [Full Text] [Related]
12. Medical and Surgical Management of Left Ventricular Assist Device-Associated Intracranial Hemorrhage.
Ibeh C; Tirschwell DL; Mahr C; Creutzfeldt CJ
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106053. PubMed ID: 34418673
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy in 2017: Advances in atherosclerosis, atrial fibrillation, and valvular disease.
Bhatt DL
Nat Rev Cardiol; 2018 Feb; 15(2):71-72. PubMed ID: 29297509
[No Abstract] [Full Text] [Related]
14. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
[TBL] [Abstract][Full Text] [Related]
15. The biological basis of thrombosis and bleeding in patients with ventricular assist devices.
John R; Lee S
J Cardiovasc Transl Res; 2009 Mar; 2(1):63-70. PubMed ID: 20559970
[TBL] [Abstract][Full Text] [Related]
16. Rotary Blood Pumps as Long-Term Mechanical Circulatory Support: A Review of a 15-Year Berlin Experience.
Hetzer R; Kaufmann MEng F; Potapov E; Krabatsch T; Delmo Walter EM
Semin Thorac Cardiovasc Surg; 2016; 28(1):12-23. PubMed ID: 27568128
[TBL] [Abstract][Full Text] [Related]
17. Long-term discontinuation of antithrombotic therapy in patients with HeartMate II continuous-flow left ventricular assist device support.
Schurr JW; Seifert FC; McLarty AJ
Int J Artif Organs; 2019 Dec; 42(12):770-774. PubMed ID: 31298625
[TBL] [Abstract][Full Text] [Related]
18. Quick reference guide to the new oral anticoagulants.
Hurst K; Lee R; Handa A
J Vasc Surg; 2016 Jun; 63(6):1653-7. PubMed ID: 27113315
[TBL] [Abstract][Full Text] [Related]
19. Cessation of anti-coagulation for bleeding and subsequent thrombosis events with a fully magnetically levitated centrifugal left ventricular assist device.
Gosev I; Ayers B; Wood K; Barrus B; Prasad S
J Heart Lung Transplant; 2019 Jul; 38(7):788-789. PubMed ID: 31101370
[No Abstract] [Full Text] [Related]
20. Science for surgeons: understanding pump thrombogenesis in continuous-flow left ventricular assist devices.
de Biasi AR; Manning KB; Salemi A
J Thorac Cardiovasc Surg; 2015 Mar; 149(3):667-73. PubMed ID: 25534307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
